Wanbury Crecimiento futuro

Future controles de criterios 0/6

Actualmente no disponemos de suficiente cobertura de analistas para prever el crecimiento y los ingresos de Wanbury.

Información clave

n/a

Tasa de crecimiento de los beneficios

n/a

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Pharmaceuticals	18.3%
Tasa de crecimiento de los ingresos	n/a
Rentabilidad financiera futura	n/a
Cobertura de analistas	None
Última actualización	n/a

Actualizaciones recientes sobre el crecimiento futuro

No hay actualizaciones

Recent updates

Wanbury Limited (NSE:WANBURY) Surges 35% Yet Its Low P/S Is No Reason For Excitement

Sep 13

Wanbury Limited (NSE:WANBURY) Might Not Be As Mispriced As It Looks

Jul 16

Statutory Earnings May Not Be The Best Way To Understand Wanbury's (NSE:WANBURY) True Position

May 24

These 4 Measures Indicate That Wanbury (NSE:WANBURY) Is Using Debt Reasonably Well

May 21

The Market Doesn't Like What It Sees From Wanbury Limited's (NSE:WANBURY) Earnings Yet

Mar 19

Wanbury Limited's (NSE:WANBURY) Shares Leap 42% Yet They're Still Not Telling The Full Story

Dec 18

Are Wanbury's (NSE:WANBURY) Statutory Earnings A Good Guide To Its Underlying Profitability?

Sep 09

En esta sección solemos presentar previsiones de crecimiento de ingresos y beneficios basadas en las estimaciones por consenso de analistas profesionales para ayudar a los inversores a comprender la capacidad de la empresa para generar beneficios. Pero como Wanbury no ha proporcionado suficientes datos anteriores y no dispone de previsiones de analistas, sus beneficios futuros no pueden calcularse de forma fiable extrapolando datos anteriores o utilizando las previsiones de los analistas.

Es una situación poco común, ya que el 97% de las empresas disponibles en SimplyWall St sí disponen de datos financieros anteriores.

Previsiones de crecimiento de beneficios e ingresos

NSEI:WANBURY - Estimaciones futuras de los analistas y datos financieros pasados (INR Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
6/30/2024	5,605	523	N/A	N/A	N/A
3/31/2024	5,756	560	-134	40	N/A
12/31/2023	5,692	233	N/A	N/A	N/A
9/30/2023	5,495	98	-27	156	N/A
6/30/2023	5,290	15	N/A	N/A	N/A
3/31/2023	4,996	-104	72	198	N/A
12/31/2022	5,011	711	N/A	N/A	N/A
9/30/2022	5,001	748	163	258	N/A
6/30/2022	5,003	751	N/A	N/A	N/A
3/31/2022	5,112	815	309	405	N/A
12/31/2021	4,972	-100	N/A	N/A	N/A
9/30/2021	4,821	-45	272	372	N/A
6/30/2021	4,532	-23	N/A	N/A	N/A
3/31/2021	3,925	-126	123	167	N/A
12/31/2020	3,391	587	N/A	N/A	N/A
9/30/2020	3,264	507	999	216	N/A
6/30/2020	3,406	541	N/A	N/A	N/A
3/31/2020	3,675	645	1,189	441	N/A
12/31/2019	4,020	-78	N/A	N/A	N/A
9/30/2019	4,099	-79	215	281	N/A
6/30/2019	3,997	-171	N/A	N/A	N/A
3/31/2019	3,914	-248	250	297	N/A
3/31/2018	3,711	-320	N/A	325	N/A
3/31/2017	4,338	620	N/A	434	N/A
3/31/2016	4,233	-71	N/A	431	N/A
3/31/2015	4,998	64	N/A	803	N/A
9/30/2014	4,412	-851	N/A	454	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Datos insuficientes para determinar si el crecimiento previsto de los beneficios de WANBURY es superior a la tasa de ahorro (6.7%).

Beneficios vs. Mercado: Datos insuficientes para determinar si se prevé que los beneficios de WANBURY crezcan más rápidamente que el mercado Indian

Beneficios de alto crecimiento: Datos insuficientes para determinar si se espera que los beneficios de WANBURY crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: No hay datos suficientes para determinar si se prevé que los ingresos de WANBURY crezcan más rápidamente que el mercado de Indian.

Ingresos de alto crecimiento: No hay datos suficientes para determinar si se prevé que los ingresos de WANBURY crezcan a un ritmo superior a 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de WANBURY se prevé que sea elevada dentro de 3 años.

Wanbury Crecimiento futuro

Future controles de criterios 0/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Wanbury Limited to Report Q2, 2025 Results on Nov 13, 2024

Wanbury Limited to Report Q2, 2025 Results on Nov 13, 2024

Wanbury Limited (NSE:WANBURY) Surges 35% Yet Its Low P/S Is No Reason For Excitement

Wanbury Limited Informs About Its New Products Launch

Wanbury Limited, Annual General Meeting, Sep 27, 2024

Wanbury Limited Announces Appointment of Pradeep Patni as CEO of India Formulation Business

Investor sentiment improves as stock rises 17%

First quarter 2025 earnings released: EPS: ₹0.32 (vs ₹1.43 in 1Q 2024)

Wanbury Limited to Report Q1, 2025 Results on Aug 12, 2024

Wanbury Limited (NSE:WANBURY) Might Not Be As Mispriced As It Looks

Investor sentiment improves as stock rises 20%

Statutory Earnings May Not Be The Best Way To Understand Wanbury's (NSE:WANBURY) True Position

New minor risk - Share price stability

These 4 Measures Indicate That Wanbury (NSE:WANBURY) Is Using Debt Reasonably Well

Full year 2024 earnings released: EPS: ₹17.10 (vs ₹3.18 loss in FY 2023)

Wanbury Limited to Report Q4, 2024 Results on May 16, 2024

Less than half of directors are independent

Investor sentiment improves as stock rises 15%

The Market Doesn't Like What It Sees From Wanbury Limited's (NSE:WANBURY) Earnings Yet

Investor sentiment deteriorates as stock falls 17%

Wanbury Limited Announces Retirement of Pallavi Prakash Shedge as Independent Director

Third quarter 2024 earnings released: EPS: ₹3.14 (vs ₹1.00 loss in 3Q 2023)

Wanbury Limited to Report Q3, 2024 Results on Jan 24, 2024

Wanbury Limited's (NSE:WANBURY) Shares Leap 42% Yet They're Still Not Telling The Full Story

Wanbury Limited Approves Appointment of Pravin Dilip Pawar as the Non-Executive Independent Director

Second quarter 2024 earnings released: EPS: ₹2.25 (vs ₹0.27 loss in 2Q 2023)

Wanbury Limited to Report Q2, 2024 Results on Oct 20, 2023

New major risk - Negative shareholders equity

Estimating The Fair Value Of Wanbury Limited (NSE:WANBURY)

Wanbury Limited, Annual General Meeting, Sep 27, 2023

Wanbury Limited Appoints Mohan Kumar Rayana as Whole Time Director

First quarter 2024 earnings released: EPS: ₹1.43 (vs ₹2.22 loss in 1Q 2023)

Wanbury Limited to Report Q1, 2024 Results on Aug 11, 2023

Not Many Are Piling Into Wanbury Limited (NSE:WANBURY) Just Yet

Full year 2023 earnings released: ₹3.18 loss per share (vs ₹25.29 profit in FY 2022)

Wanbury Limited to Report Q4, 2023 Results on Jun 26, 2023

Investor sentiment improves as stock rises 19%

Wanbury Limited to Report Q4, 2023 Results on May 30, 2023

Investor sentiment improves as stock rises 24%

Third quarter 2023 earnings released: ₹1.00 loss per share (vs ₹0.12 profit in 3Q 2022)

Wanbury Limited to Report Q3, 2023 Results on Feb 14, 2023

Second quarter 2023 earnings released: ₹0.27 loss per share (vs ₹0.17 loss in 2Q 2022)

Investor sentiment deteriorated over the past week

Wanbury Limited to Report Q2, 2023 Results on Nov 11, 2022

Investor sentiment improved over the past week

Wanbury Limited, Annual General Meeting, Sep 28, 2022

First quarter 2023 earnings released: ₹2.22 loss per share (vs ₹0.28 loss in 1Q 2022)

Investor sentiment improved over the past week

Wanbury Limited to Report Q1, 2023 Results on Aug 10, 2022

Investor sentiment improved over the past week

Full year 2022 earnings released: EPS: ₹25.29 (vs ₹5.04 loss in FY 2021)

Wanbury Limited to Report Q4, 2022 Results on Jun 22, 2022

Wanbury Limited announced that it expects to receive INR 143.0625 million in funding from Expert Chemicals (India) Pvt. Ltd.

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Wanbury Limited to Report Q3, 2022 Results on Feb 08, 2022

Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Calculating The Intrinsic Value Of Wanbury Limited (NSE:WANBURY)

First quarter 2022 earnings released: ₹0.28 loss per share (vs ₹4.47 loss in 1Q 2021)

Full year 2021 earnings released: ₹5.04 loss per share (vs ₹26.90 profit in FY 2020)

Wanbury Limited announced that it has received INR 494.999765 million in funding from Bakliwal Fincom Pvt Ltd, Radhakrishna Ramnarain Private Limited, Niche Financial Services Pvt. Ltd, Vidyut Merchandise Pvt Ltd, Dalal & Broacha Stock Broking Pvt Ltd., Asset Management Arm and other investors

A Look At The Fair Value Of Wanbury Limited (NSE:WANBURY)

Investor sentiment improved over the past week

New 90-day high: ₹93.80

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS ₹2.36 (vs ₹0.90 loss in 3Q 2020)

Wanbury Limited Approves Board Appointments

Wanbury Limited to Report Q3, 2021 Results on Feb 12, 2021

New 90-day high: ₹60.00

Investor sentiment improved over the past week

New 90-day high: ₹42.35

A Look At The Fair Value Of Wanbury Limited (NSE:WANBURY)

New 90-day high: ₹38.00

Wanbury Limited to Report Q2, 2021 Results on Nov 12, 2020

Are Wanbury's (NSE:WANBURY) Statutory Earnings A Good Guide To Its Underlying Profitability?

Wanbury Limited to Report Q1, 2021 Results on Sep 11, 2020